CapsoVision (CV) Share-based Compensation (2024 - 2025)

CapsoVision's (CV) quarterly Share-based Compensation came in at $197000.0 in Q4 2025, up 74.34% year-on-year from $113000.0 in Q4 2024, and down 35.83% quarter-over-quarter from $307000.0 in Q3 2025.

CapsoVision (CV) Share-based Compensation (2024 - 2025) Analysis & Trends

CapsoVision has disclosed Share-based Compensation across 2 years of filings, most recently posting $197000.0 for Q4 2025.

  • Share-based Compensation for Q4 2025 came in at $197000.0, up 74.34% year-over-year; the trailing twelve-month figure through Dec 2025 was $632000.0 (changed N/A YoY), and the FY2025 annual result was $826000.0, up 429.49% from the prior year.
  • Share-based Compensation came in at $197000.0 for Q4 2025 at CapsoVision, down from $307000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $307000.0 in Q3 2025 to a low of $15000.0 in Q3 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 317.00 Mn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 87.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 94.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 83.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 45.40 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 35.12 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 43.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 35.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 12.90 Mn
10 CapsoVision 161.82 Mn 151.71 Mn 1.95 Mn 197,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 197,000.00
Dec 31, 2025 197,000.00
Sep 30, 2025 307,000.00
Sep 30, 2025 307,000.00
Dec 31, 2024 113,000.00
Dec 31, 2024 113,000.00
Sep 30, 2024 15,000.00
Sep 30, 2024 15,000.00